Arcturus Therapeutics Holdings Inc Equity-NMS: ARCT

$9.11 -0.38 (April 5, 2025)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Error in Fetching Data, Please retry later.
Previous close :$9.485
Open :$9.12
Today's high :$9.35
Today's low :$8.7
52W low :$8.7
52W high :$45
EPS(TTM): :-3
Shares O/S :27.12 M
Market cap :247.06 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Arcturus Therapeutics Holdings Inc $9.11 -0% - 247.06M

Frequently Asked Questions

What is the share price of Arcturus Therapeutics Holdings Inc today?

Arcturus Therapeutics Holdings Inc (ARCT) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics Holdings Inc. is a commercial mRNA medicines and vaccines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. The Company with enabling technologies, including LUNAR lipid-mediated delivery, STARR mRNA technology (sa-mRNA) and mRNA drug substances along with drug product manufacturing. It has developed KOSTAIVE, a self-amplifying messenger RNA (sa-mRNA) COVID vaccine. The Company’s pipeline includes RNA therapeutic candidates to potentially treat ornithine transcarbamylase (OTC) deficiency and cystic fibrosis (CF), along with its partnered mRNA vaccine programs for SARS-CoV-2 (COVID-19) and influenza. The Company's versatile RNA therapeutics platforms can be applied to multiple types of nucleic acid medicines, including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics.